Evaluation of long-term results of using the drug Fertiwell: impact on the likelihood of conception and pregnancy outcome
- Autores: Spivak L.G.1, Gamidov S.I.2, Al-Shukri S.H.3, Morozov A.O.4, Androsov А.А.4, Popova А.Y.2, Kupriyanov Y.A.5, Pushkar D.Y.5
-
Afiliações:
- I.M. Sechenov First Moscow State Medical University
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia
- Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
- Sechenov First Moscow State Medical University
- Russian University of Medicine
- Edição: Nº 6 (2023)
- Páginas: 72-79
- Seção: Andrology
- URL: https://journals.eco-vector.com/1728-2985/article/view/626170
- DOI: https://doi.org/10.18565/urology.2023.6.72-79
- ID: 626170
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Introduction. Current methods of treating male infertility have limited efficiency, since they are aimed to individual stages of the pathogenesis. Preparations based on testicular regulatory polypeptides are the most physiological and universal, owing to a complex effect on the self-regulation of testicular tissue.
Aim. To study the delayed efficiency and safety of therapy with Fertiwell in patients with pathospermia and to assess the frequency of conception and pregnancy outcome in their partners based on the collection, analysis and interpretation of medical data.
Materials and methods. A telephone survey of patients participating in the phase III clinical trial was carried out. The fact of conception in a couple was assessed over a period of 1 to 9 months after completion of therapy, as well as time from completion of the course to conception, pregnancy outcomes, newborn health outcomes.
Results. In the period from 1 to 9 months after completion of therapy, pregnancy occurred in 17 out of 34 couples (50%) in the Fertiwell group and in 13 out of 42 couples (30.95%) in the placebo group. This difference was statistically and clinically significant (p<0.05). All pregnancies resulted in a live birth. The median time from completion of the course to conception was 4 months in Fertiwell group and 6 months in the placebo group. There were no significant differences in anthropometric parameters of newborns between the two groups (p>0.05).
Conclusion. When using the drug Fertiwell, pregnancy and live birth rate was significantly higher (2.23 times) compared to the control group. There was a trend toward earlier pregnancies in partners of men receiving Fertiwell. Thus, this drug can be recommended for the treatment of men with idiopathic infertility as monotherapy, as well as in combination with assisted reproductive technologies.
Texto integral
Sobre autores
L. Spivak
I.M. Sechenov First Moscow State Medical University
Autor responsável pela correspondência
Email: leonid.spivak@gmail.com
Ph.D., MD, professor, urologist, Institute for Urology and Reproductive Health
Rússia, MoscowS. Gamidov
National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia
Email: leonid.spivak@gmail.com
Ph.D., MD, professor, urologist, andrologist, ultrasound diagnostic doctor, Head of the Department of Andrology and Urology
Rússia, MoscowS. Al-Shukri
Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia
Email: al-shukri@spbmedu.ru
Ph.D., MD, professor, Chief Urologist of the Northwestern Federal District, Honored Physician of the Russian Federation, Board Member of the Russian Society of Urologists (RSU), Head of the Department of Urology with clinic and postgraduate education
Rússia, Saint PetersburgA. Morozov
Sechenov First Moscow State Medical University
Email: andrei.o.morozov@gmail.com
Ph.D., senior researcher, urologist, Institute for Urology and Reproductive Health
Rússia, MoscowА. Androsov
Sechenov First Moscow State Medical University
Email: aleksandrr_androsov@mail.ru
resident, Department of the Pediatric surgery, urology and andrology named after professor L.P. Alexandrov
Rússia, MoscowА. Popova
National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia
Email: secretariat@oparina4.ru
Ph.D., associate professor, senior researcher, urologist at the Department of Andrology and Urology
Rússia, MoscowYu. Kupriyanov
Russian University of Medicine
Email: urodepatment@mail.ru
Ph.D., urologist of the Highest Qualifying Category, Deputy Chief Urologist of Moscow Health Department, Deputy Chairman of the expert group for certification of urologists of the Moscow Healthcare Department
Rússia, MoscowD. Pushkar
Russian University of Medicine
Email: urodepatment@mail.ru
Ph.D., MD, Professor, Academician of RAS, Honored Physician of the Russian Federation, Honored Scientist of the Russian Federation, Chief urologist of the Ministry of Health of Russia, Head of the Department of Urology
Rússia, MoscowBibliografia
- WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press; 2000.
- Salonia A., Bettocchi C., Capogrosso P., Carvalho J., Corona G., Hatzichristodoulou G., et al. EAU Guidelines on Sexual and Reproductive Health 2023.
- Chehab M., Madala A., Trussell J.C. On-label and off-label drugs used in the treatment of male infertility. Fertil Steril. 2015;103:595–604. https://doi.org/10.1016/j.fertnstert.2014.12.122
- Agarwal A., Parekh N., Selvam M.K.P., Henkel R., Shah R., Homa S.T., et al. Male oxidative stress infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World J Men'S Heal. 2019;37:296–312. https://doi.org/10.5534/wjmh.190055
- Sharma A., Minhas S., Dhillo W.S., Jayasena C.N. Male infertility due to testicular disorders. J Clin Endocrinol Metab 2021;106:E442–459. https://doi.org/10.1210/clinem/dgaa781
- Sengupta P., Roychoudhury S., Nath M., Dutta S. Oxidative Stress and Idiopathic Male Infertility. Adv. Exp. Med. Biol., vol. 1358, Adv Exp Med Biol; 2022, p. 181–204. https://doi.org/10.1007/978-3-030-89340-8_9
- Agarwal A., Durairajanayagam D., Halabi J., Peng J., Vazquez-Levin M. Proteomics, oxidative stress and male infertility. Reprod Biomed Online 2014;29:32–58. https://doi.org/10.1016/j.rbmo.2014.02.013
- Aitken R.J. Oxidative stress and the etiology of male infertility. J Assist Reprod Genet 2016;33:1691–1692. https://doi.org/10.1007/s10815-016-0791-4
- Bui A.D., Sharma R., Henkel R., Agarwal A. Reactive oxygen species impact on sperm DNA and its role in male infertility. Andrologia 2018;50. https://doi.org/10.1111/and.13012
- Agarwal A., Sharma R.K., Nallella K.P., Thomas A.J., Alvarez J.G., Sikka S.C. Reactive oxygen species as an independent marker of male factor infertility. Fertil Steril 2006;86:878–885. https://doi.org/10.1016/j.fertnstert.2006.02.111
- Tremellen K. Oxidative stress and male infertility – A clinical perspective. Hum Reprod Update 2008;14:243–258. https://doi.org/10.1093/humupd/dmn004
- Wagner H., Cheng J.W., Ko E.Y. Role of reactive oxygen species in male infertility: An updated review of literature. Arab J Urol 2018;16:35–43. https://doi.org/10.1016/j.aju.2017.11.001
- Li K.P., Yang X.S., Wu T. The Effect of Antioxidants on Sperm Quality Parameters and Pregnancy Rates for Idiopathic Male Infertility: A Network Meta-Analysis of Randomized Controlled Trials. Front Endocrinol (Lausanne) 2022;13. https://doi.org/10.3389/fendo.2022.810242
- Sharma A.P., Sharma G., Kumar R. Systematic Review and Meta-analysis on Effect of Carnitine, Coenzyme Q10 and Selenium on Pregnancy and Semen Parameters in Couples With Idiopathic Male Infertility. Urology 2022;161:4–11. https://doi.org/10.1016/j.urology.2021.10.041
- Ioannidou P.G., Papanikolaou D.A., Bosdou J.K., Goulis D.G., Lambropoulos A.F., Grimbizis G.F., et al. Improvement in sperm quality by oral antioxidant supplementation in infertile men with varicocele who have not undergone surgical repair: Systematic review and meta-analysis. Andrologia 2022;54. https://doi.org/10.1111/and.14533
- de Ligny W., Smits R.M., Mackenzie-Proctor R., Jordan V., Fleischer K., de Bruin J.P., et al. Antioxidants for male subfertility. Cochrane Database Syst Rev 2022;2022. https://doi.org/10.1002/14651858.CD007411.pub5
- Su L., Qu H., Cao Y., Zhu J., Zhang S.Z., Wu J., et al. Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Adv Nutr 2022;13:586–594. https://doi.org/10.1093/advances/nmab127
- Gunes S., Esteves S.C. Role of genetics and epigenetics in male infertility. Andrologia 2021;53. https://doi.org/10.1111/and.13586
- Leslie S.W., Soon-Sutton T.L., Khan M.A. Male Infertility. StatPearls 2023.
- Agarwal A., Baskaran S., Parekh N., Cho C.L., Henkel R., Vij S., et al. Male infertility. Lancet 2021;397:319–333. https://doi.org/10.1016/S0140-6736(20)32667-2
- Cannarella R., Condorelli R.A., Mongioì L.M., Barbagallo F., Calogero A.E, La Vignera S. Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis. Expert Opin Pharmacother 2019;20:1517–1525. https://doi.org/10.1080/14656566.2019.1615057
- Chua M.E., Escusa K.G., Luna S., Tapia L.C., Dofitas B., Morales M. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: A meta-analysis. Andrology 2013;1:749–757. https://doi.org/10.1111/j.2047-2927.2013.00107.x
- Ring J.D., Lwin A.A., Köhler T.S. Current medical management of endocrine-related male infertility. Asian J Androl 2016;18:357–363. https://doi.org/10.4103/1008-682X.179252.
- Xu X, Sun M, Ye J, Luo D, Su X, Zheng D, et al. The Effect of Aromatase on the Reproductive Function of Obese Males. Horm Metab Res 2017;49:572–9. https://doi.org/10.1055/s-0043-107835
- Del Giudice F., Busetto G., De Berardinis E., Sperduti I., Ferro M., Maggi M, et al. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility. Asian J Androl 2020;22:360–367. https://doi.org/10.4103/aja.aja_101_19
- Li H., Liu S., Wu S., Ge R., Yan Cheng C.. NC1-Peptide from collagen α3 (IV) chains in the basement membrane of testes regulates spermatogenesis via p-FAK-Y407. Endocrinol (United States) 2020;161. https://doi.org/10.1210/endocr/bqaa133
- Li L., Li H., Wang L., Bu T., Liu S., Mao B., et al. A local regulatory network in the testis mediated by laminin and collagen fragments that supports spermatogenesis. Crit Rev Biochem Mol Biol 2021;56:236–254. https://doi.org/10.1080/10409238.2021.1901255
- Amaral A., Castillo J., Ramalho-Santos J., Oliva R. The combined human sperm proteome: Cellular pathways and implications for basic and clinical science. Hum Reprod Update 2014;20:40–62. https://doi.org/10.1093/humupd/dmt046
- Griswold M.D. 50 years of spermatogenesis: Sertoli cells and their interactions with germ cells. Biol Reprod 2018;99:87–100. https://doi.org/10.1093/biolre/ioy027
- Samanta L., Agarwal A., Swain N., Sharma R., Gopalan B., Esteves S.C., et al. Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Use as Biomarkers of Varicocele Associated Infertility. J Urol 2018;200:414–422. https://doi.org/10.1016/j.juro.2018.03.009
- Hetherington L., Schneider E.K., DeKretser D., Muller C.H., Hondermarck H., Velkov T., et al. Deficiency in outer dense fiber 1 is a marker and potential driver of idiopathic male infertility. Mol Cell Proteomics 2016;15:3685–3693. https://doi.org/10.1074/mcp.M116.060343
- Khochenkova Y.A., Machkova Y.S., Khochenkov D.A., Safarova E.R., Bastrikova N.A. Biological activity of a drug, polypeptides derived from testes in a model of oxidative stress in vitro. Exp Сlinical Urol 2022;15:18–26. https://doi.org/10.29188/2222-8543-2022-15-3-18-26
- Khochenkova Y.A., Machkova Y.S., Khochenkova D.A, Sidorova T.A, Safarova ER, Bastrikova NA, et al. A STUDY OF THE MECHANISMS OF ACTION OF FERTIWELL IN VIVO. Urologiia 2023;2023:60–70. https://doi.org/10.18565/urology.2023.1.60-70
- Pushkar D.Y., Kupriyanov Y.A., Gamidov S.I., Teteneva A.V., Spivak L.G., Shormanov I.S., et al. Assessment of the safety and efficacy of medicinal product PPR-001 based on regulatory polypeptides of the testes. Urologiia. 2021;2021:100–108. https://doi.org/10.18565/urology.2021.6.100-108
- Evans E.P.P., Scholten J.T.M., Mzyk A., Reyes-San-Martin C., Llumbet A.E., Hamoh T., et al. Male subfertility and oxidative stress. Redox Biol 2021;46. https://doi.org/10.1016/J.REDOX.2021.102071
- Becatti M., Cito G., Argento F.R., Fini E., Bettiol A., Borghi S., et al. Blood Leukocyte ROS Production Reflects Seminal Fluid Oxidative Stress and Spermatozoa Dysfunction in Idiopathic Infertile Men. Antioxidants 2023;12. https://doi.org/10.3390/antiox12020479.